To simulate this process, different tumor cells received IFN-γ, nintedanib, or a combination treatment and the expression of MHC-I (β2M, H-2kb and H-2kd), TAP1 and PD-L1 was analyzed by western blot or flow cytometry. The gene discussed is B2M; the disease is neoplasm.